The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era
- 16 August 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 22 (10) , 1412-1414
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- No one is safe until everyone is safe—from polio tooBMJ, 2022
- Global epidemiology of vaccine-derived poliovirus 2016–2021: A descriptive analysis and retrospective case-control studyeClinicalMedicine, 2022
- Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing — Worldwide, March–October 2021MMWR. Morbidity and Mortality Weekly Report, 2022
- U.S. bound journey of migrant peoples InTransit across Dante's Inferno and Purgatory in the AmericasTravel Medicine and Infectious Disease, 2022
- Public health concerns over polio in war‐torn Ukraine and nearby regions: Four lessons and a warning from the history of epidemicsJournal of Medical Virology, 2022
- Current Challenges to Achieving a Polio Free WorldAnnals of the Academy of Medicine, Singapore, 2020
- Preventing paralytic polio caused by vaccine-derived poliovirus type 2The Lancet Infectious Diseases, 2020